Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Verigen and Tufts to develop transgenic pigs to produce humanized antibodies

April 10, 1997

Penederm and SmithKline Beecham announce OTC collaboration

April 10, 1997

New thrombin receptor cloned and characterized

April 10, 1997

Small-molecule drug discovery collaboration between Chiroscience and Alcon

April 9, 1997

Aradigm's SmartMist covered by U.S. patent

April 9, 1997

NIH seeks licensees for method of characterizing/screening/detecting DNA-binding ligands

April 9, 1997

Abgenix, JT and GenPharm sign crosslicensing agreement for human MAb technologies

April 7, 1997

Novel drug delivery system from Brown University shows promise

April 4, 1997

Electroporation shown to be effective for local delivery of agents for restenosis

April 3, 1997

Sheffield licenses Siemens multidose inhaler

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.